Table 1 Patient demographics for the study group
From: Comparison of transforming growth factor beta expression in healthy and diseased human tendon
Cohort | n | Median age (years) | Sex (M:F) | History | Treatment | Median OSS |
|---|---|---|---|---|---|---|
Healthy supraspinatus | 10 | 24 (18–29) | 9:1 | Shoulder instability | Shoulder stabilisation | N/A |
Healthy hamstring (mRNA) | 7 | 31 (22–49) | 3:4 | ACL rupture | ACL repair | N/A |
Tendinopathic supraspinatus | 23 | 54 (36–73) | 13:10 | Shoulder Sx 1–10 years (mean 2.5 years) | 1–2 steroid injections, SAD ± PRP | 29 (11–38) |
Torn supraspinatus | 30 | 69.5 (50–78) | 18:12 | 5 small | Rotator cuff repair | 20.5 (7–35) |
9 medium | ||||||
9 large | ||||||
7 massive | ||||||
Torn supraspinatus (mRNA) | 7 | 52.5 (40–67) | 5:2 | 3 medium | Rotator cuff repair | 26 (9–31) |
2 large | ||||||
2 massive |